- Home
- HFFG vs NBTX Comparison
HFFG vs NBTX Comparison
Compare HFFG & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HFFG
- NBTX
- Stock Information
- Founded
- HFFG N/A
- NBTX 2003
- Country
- HFFG United States
- NBTX France
- Employees
- HFFG N/A
- NBTX N/A
- Industry
- HFFG Food Distributors
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- HFFG Consumer Discretionary
- NBTX Health Care
- Exchange
- HFFG Nasdaq
- NBTX Nasdaq
- Market Cap
- HFFG 180.3M
- NBTX 201.9M
- IPO Year
- HFFG N/A
- NBTX 2020
- Fundamental
- Price
- HFFG $3.20
- NBTX $3.00
- Analyst Decision
- HFFG
- NBTX Strong Buy
- Analyst Count
- HFFG 0
- NBTX 1
- Target Price
- HFFG N/A
- NBTX $12.00
- AVG Volume (30 Days)
- HFFG 45.1K
- NBTX 69.0K
- Earning Date
- HFFG 11-12-2024
- NBTX 12-31-2024
- Dividend Yield
- HFFG N/A
- NBTX N/A
- EPS Growth
- HFFG N/A
- NBTX N/A
- EPS
- HFFG N/A
- NBTX N/A
- Revenue
- HFFG $1,177,258,000.00
- NBTX $45,220,186.00
- Revenue This Year
- HFFG $5.18
- NBTX N/A
- Revenue Next Year
- HFFG $2.73
- NBTX N/A
- P/E Ratio
- HFFG N/A
- NBTX N/A
- Revenue Growth
- HFFG 1.53
- NBTX 526.17
- 52 Week Low
- HFFG $2.46
- NBTX $2.76
- 52 Week High
- HFFG $5.91
- NBTX $8.96
- Technical
- Relative Strength Index (RSI)
- HFFG 34.42
- NBTX 37.26
- Support Level
- HFFG $3.20
- NBTX $2.89
- Resistance Level
- HFFG $3.79
- NBTX $3.30
- Average True Range (ATR)
- HFFG 0.18
- NBTX 0.30
- MACD
- HFFG -0.07
- NBTX 0.01
- Stochastic Oscillator
- HFFG 0.53
- NBTX 13.75
About HFFG HF Foods Group Inc.
HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The Company's business consists of one operating segment; HF Group, which operates solely in the United States. The Company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.